Alcohol, one-carbon nutrient intake, and risk of colorectal cancer according to tumor methylation level of IGF2 differentially methylated region.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 25411283)

Published in Am J Clin Nutr on October 08, 2014

Authors

Reiko Nishihara1, Molin Wang1, Zhi Rong Qian1, Yoshifumi Baba1, Mai Yamauchi1, Kosuke Mima1, Yasutaka Sukawa1, Sun A Kim1, Kentaro Inamura1, Xuehong Zhang1, Kana Wu1, Edward L Giovannucci1, Andrew T Chan1, Charles S Fuchs1, Shuji Ogino1, Eva S Schernhammer1

Author Affiliations

1: From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (RN, ZRQ, MY, KM, YS, SAK, KI, CSF, and SO); the Departments of Nutrition (RN, KW, and ELG), Epidemiology (MW, ELG, SO, and ESS), and Biostatistics (MW), Harvard School of Public Health, Boston, MA; the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (MW, XZ, KW, ELG, ATC, CSF, and ESS); the Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan (YB); the Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); and Applied Cancer Research-Institution for Translational Research Vienna, Vienna, Austria (ESS).

Articles cited by this

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature (2000) 14.91

CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature (2000) 12.97

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85

DNA methylation: roles in mammalian development. Nat Rev Genet (2013) 6.65

Applying Cox regression to competing risks. Biometrics (1995) 6.32

The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol (1988) 5.32

Competing risk regression models for epidemiologic data. Am J Epidemiol (2009) 4.75

Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01

Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med (1998) 3.73

Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst (1993) 3.25

Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (1993) 3.24

Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. Cancer Res (2002) 3.21

Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst (1995) 3.10

Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J Biol Chem (2000) 2.60

Aspirin use and risk of colorectal cancer according to BRAF mutation status. JAMA (2013) 2.26

Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology (2004) 2.06

Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int J Mol Sci (2013) 2.00

Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95

Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen (2004) 1.94

Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84

Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res (2007) 1.65

Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer (2002) 1.55

Meta-analysis of published data using a linear mixed-effects model. Biometrics (1996) 1.55

Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut (2009) 1.54

Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer. Hum Mol Genet (2008) 1.47

Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J Inherit Metab Dis (2010) 1.40

Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitamin B-12, and vitamin B-6 status. Am J Clin Nutr (1996) 1.38

Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol (2014) 1.35

Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) (2013) 1.33

Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig. Proc Natl Acad Sci U S A (2002) 1.28

Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst (2012) 1.24

Chronic alcohol consumption induces genomic but not p53-specific DNA hypomethylation in rat colon. J Nutr (1999) 1.22

Alcohol, DNA methylation, and cancer. Alcohol Res (2013) 1.14

Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology (2008) 1.06

One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study. Cancer Causes Control (2009) 1.04

Biological significance of the CpG island methylator phenotype. Biochem Biophys Res Commun (2014) 1.04

DNA methylation as an epigenetic biomarker in colorectal cancer. Oncol Lett (2013) 1.03

Alcohol metabolism and epigenetics changes. Alcohol Res (2013) 1.03

Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastroenterology (2010) 1.01

B vitamins, methionine and alcohol intake and risk of colon cancer in relation to BRAF mutation and CpG island methylator phenotype (CIMP). PLoS One (2011) 1.01

Frequent loss of imprinting of IGF2 and MEST in lung adenocarcinoma. Mol Carcinog (2001) 0.98

Deregulation of an imprinted gene network in prostate cancer. Epigenetics (2014) 0.93

Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr Cancer (2011) 0.92

Effect of chronic alcohol consumption on total plasma homocysteine level in rats. Alcohol Clin Exp Res (2000) 0.91

Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting system. Mol Cancer (2012) 0.84

Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer. Int J Cancer (2010) 0.83

IGF2 DMR0 methylation, loss of imprinting, and patient prognosis in esophageal squamous cell carcinoma. Ann Surg Oncol (2013) 0.82

Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older women. Cancer Epidemiol Biomarkers Prev (2013) 0.82

Prospective study of alcohol consumption and the risk of colorectal cancer before and after folic acid fortification in the United States. Ann Epidemiol (2013) 0.82

Gene therapy for cancer through adenovirus vector‑mediated expression of the Ad5 early region gene 1A based on loss of IGF2 imprinting. Oncol Rep (2013) 0.81

A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies. Cancer Epidemiol Biomarkers Prev (2013) 0.80